Daiichi Sankyo Company, Limited ( OTCPK:DSNKY) Discusses ESMO 2025 Highlights With Focus on Key Breast Cancer Trial Data and Regulatory Submissions October 21, 2025 8:00 AM EDT ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
Next time you're on social media consider this: one study evaluating influencer posts on Instagram found that 86 percent of nutrition content didn’t cite any scientific sources—and other research ...
Final Destination has made its bones bringing audiences’ worst fears to the big screen. Through a twisted mix of horror and absurdity, the franchise explores the cosmic balance of life and death, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback